{"id":"W2913987637","doi":"10.1200/jco.18.00915","title":"DYNAMO: A Phase II Study of Duvelisib (IPI-145) in Patients With Refractory Indolent Non-Hodgkin Lymphoma","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":264,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Cégep de l'Outaouais; McGill University","funders":"Verastem Oncology","keywords":"Medicine; Internal medicine; Refractory (planetary science); Neutropenia; Tolerability; Rituximab; Adverse effect; Lymphoma; Gastroenterology; Nausea; Oncology; Surgery; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001533285,0.0001970733,0.002074997,0.0002503086,0.00002445561,0.000004552418,0.0001701611,0.0002800141,0.0001415738],"category_scores_gemma":[0.0005660027,0.0001189146,0.0002873349,0.0002024408,0.00008742577,0.0001289671,0.00009193931,0.0003845569,0.00001913404],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005007269,"about_ca_system_score_gemma":0.001396575,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000928511,"about_ca_topic_score_gemma":0.000105923,"domain_scores_codex":[0.9957961,0.0003409914,0.002689264,0.0002638164,0.0006615297,0.0002482552],"domain_scores_gemma":[0.9955527,0.00104828,0.002246447,0.0003426114,0.0004949244,0.0003150847],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01783752,0.1173704,0.7245972,0.00001967368,0.0005038562,0.0004921565,0.0005186934,0.000009377929,0.00000822459,0.000003987438,0.0003571791,0.1382817],"study_design_scores_gemma":[0.1351339,0.2166217,0.6450533,0.0001843674,0.0002800665,0.00002017773,0.0003349821,0.00002036708,0.0000182631,0.000005633766,0.00225598,0.00007128847],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968758,0.00008915374,0.000002047877,0.0004352684,0.0007609208,0.0008462322,0.000004976224,0.000004053391,0.0009815666],"genre_scores_gemma":[0.9986864,0.00008999604,0.0003446281,0.0005749844,0.0001876758,0.0000114233,0.000004557488,0.00001993247,0.00008040371],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1382104,"threshold_uncertainty_score":0.4849197,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04454469984713691,"score_gpt":0.4284871544306216,"score_spread":0.3839424545834846,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}